These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 31536952)
21. Antioxidant and glycohydrolase inhibitory behavior of curcumin-based compounds: Synthesis and evaluation of anti-diabetic properties in vitro. Mehrabi M; Esmaeili S; Ezati M; Abassi M; Rasouli H; Nazari D; Adibi H; Khodarahmi R Bioorg Chem; 2021 May; 110():104720. PubMed ID: 33662896 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and da Silva SEB; da Silva Moura JA; Branco Júnior JF; de Moraes Gomes PAT; de Paula SKS; Viana DCF; de Freitas Ramalho EAV; de Melo Gomes JV; Pereira MC; da Rocha Pitta MG; da Rocha Pitta I; da Rocha Pitta MG Curr Top Med Chem; 2024; 24(14):1264-1277. PubMed ID: 38523516 [TBL] [Abstract][Full Text] [Related]
23. Design and Discovery of Some Novel Chalcones as Antioxidant and Anti-Inflammatory Agents via Attenuating NF-κB. Chu J; Guo CL Arch Pharm (Weinheim); 2016 Jan; 349(1):63-70. PubMed ID: 26660296 [TBL] [Abstract][Full Text] [Related]
24. Rational design and synthesis of some PPAR-γ agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones. Chhajed SS; Chaskar S; Kshirsagar SK; Haldar GM; Kar Mahapatra D Comput Biol Chem; 2017 Apr; 67():260-265. PubMed ID: 28193552 [TBL] [Abstract][Full Text] [Related]
25. Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors. Toumi A; Boudriga S; Hamden K; Sobeh M; Cheurfa M; Askri M; Knorr M; Strohmann C; Brieger L Bioorg Chem; 2021 Jan; 106():104507. PubMed ID: 33288322 [TBL] [Abstract][Full Text] [Related]
26. The effect of 1,3-diaryl-[1H]-pyrazole-4-acetamides on glucose utilization in ob/ob mice. Bebernitz GR; Argentieri G; Battle B; Brennan C; Balkan B; Burkey BF; Eckhardt M; Gao J; Kapa P; Strohschein RJ; Schuster HF; Wilson M; Xu DD J Med Chem; 2001 Aug; 44(16):2601-11. PubMed ID: 11472214 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists. Nazreen S; Alam MS; Hamid H; Yar MS; Shafi S; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Ali Y; Kharbanda C; Pillai KK Eur J Med Chem; 2014 Nov; 87():175-85. PubMed ID: 25255433 [TBL] [Abstract][Full Text] [Related]
28. Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from Alqahtani AS; Hidayathulla S; Rehman MT; ElGamal AA; Al-Massarani S; Razmovski-Naumovski V; Alqahtani MS; El Dib RA; AlAjmi MF Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905962 [No Abstract] [Full Text] [Related]
29. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents. Avupati VR; Yejella RP; Akula A; Guntuku GS; Doddi BR; Vutla VR; Anagani SR; Adimulam LS; Vyricharla AK Bioorg Med Chem Lett; 2012 Oct; 22(20):6442-50. PubMed ID: 22981328 [TBL] [Abstract][Full Text] [Related]
30. Novel dihydropyrimidines and its pyrazole derivatives: synthesis and pharmacological screening. Ramesh B; Bhalgat CM Eur J Med Chem; 2011 May; 46(5):1882-91. PubMed ID: 21414695 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids. Cottineau B; Toto P; Marot C; Pipaud A; Chenault J Bioorg Med Chem Lett; 2002 Aug; 12(16):2105-8. PubMed ID: 12127514 [TBL] [Abstract][Full Text] [Related]
32. Synthetic Strategies of Thiazolidine-2,4-dione Derivatives for the Development of New Anti-diabetic Agents: Compressive Review. Ray PK; Shabana K; Salahuddin ; Kumar R Curr Top Med Chem; 2024; 24(10):885-928. PubMed ID: 38500288 [TBL] [Abstract][Full Text] [Related]
33. Integrated fragment-based drug design and virtual screening techniques for exploring the antidiabetic potential of thiazolidine-2,4-diones: Design, synthesis and in vivo studies. Gupta S; Baweja GS; Singh S; Irani M; Singh R; Asati V Eur J Med Chem; 2023 Dec; 261():115826. PubMed ID: 37793328 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of Pyrazolo[3,4-b]pyridine Derivatives and Their In-Vitro and In-Silico Antidiabetic Activities. Rafique I; Maqbool T; Javed MS J Cell Biochem; 2024 Oct; 125(10):e30646. PubMed ID: 39239805 [TBL] [Abstract][Full Text] [Related]